Matej Mikulic
Research expert covering health, pharma & medtech
Amgen - Statistics & Facts
Amgen is widely described as the world鈥檚 largest pure-play medical biotechnology company, combining a biotech-led identity with the commercial reach of a global pharmaceutical player. In 2025, the company generated nearly 37 billion U.S. dollars in revenue and delivered over nine billion dollars in operating profit, underscoring a sizeable earnings base that can support both steady execution in established franchises and continued investment in future growth drivers. This scale matters because it gives Amgen room to pursue several priorities at once鈥攄efending mature products, scaling newer contributors, and funding late-stage development鈥攚ithout the narrative hinging on a single product cycle.聽
